CN101641111B - 包含用于治疗肥胖症的菜蓟与菜豆提取物的制剂 - Google Patents

包含用于治疗肥胖症的菜蓟与菜豆提取物的制剂 Download PDF

Info

Publication number
CN101641111B
CN101641111B CN200880007206XA CN200880007206A CN101641111B CN 101641111 B CN101641111 B CN 101641111B CN 200880007206X A CN200880007206X A CN 200880007206XA CN 200880007206 A CN200880007206 A CN 200880007206A CN 101641111 B CN101641111 B CN 101641111B
Authority
CN
China
Prior art keywords
extract
artichoke
kidney bean
composition
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880007206XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101641111A (zh
Inventor
E·邦巴尔代利
G·丰塔纳
A·焦里
P·莫拉佐尼
C·蓬佐内
M·龙基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Publication of CN101641111A publication Critical patent/CN101641111A/zh
Application granted granted Critical
Publication of CN101641111B publication Critical patent/CN101641111B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN200880007206XA 2007-03-07 2008-03-06 包含用于治疗肥胖症的菜蓟与菜豆提取物的制剂 Expired - Fee Related CN101641111B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US90532007P 2007-03-07 2007-03-07
EP07425132.3 2007-03-07
EP07425132A EP1967198B1 (en) 2007-03-07 2007-03-07 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity
US60/905,320 2007-03-07
PCT/EP2008/001787 WO2008107184A1 (en) 2007-03-07 2008-03-06 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity

Publications (2)

Publication Number Publication Date
CN101641111A CN101641111A (zh) 2010-02-03
CN101641111B true CN101641111B (zh) 2012-05-23

Family

ID=38229761

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880007206XA Expired - Fee Related CN101641111B (zh) 2007-03-07 2008-03-06 包含用于治疗肥胖症的菜蓟与菜豆提取物的制剂

Country Status (19)

Country Link
US (2) US7887854B2 (enExample)
EP (1) EP1967198B1 (enExample)
JP (1) JP5355424B2 (enExample)
KR (1) KR101456555B1 (enExample)
CN (1) CN101641111B (enExample)
AT (1) ATE431155T1 (enExample)
AU (1) AU2008224057B2 (enExample)
BR (1) BRPI0808563B1 (enExample)
CA (1) CA2680078C (enExample)
DE (1) DE602007001128D1 (enExample)
DK (1) DK1967198T3 (enExample)
ES (1) ES2323815T3 (enExample)
IL (1) IL200709A (enExample)
NO (1) NO339322B1 (enExample)
PL (1) PL1967198T3 (enExample)
PT (1) PT1967198E (enExample)
RU (1) RU2453323C2 (enExample)
SI (1) SI1967198T1 (enExample)
WO (1) WO2008107184A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052450A1 (it) 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
CN105816498A (zh) 2009-04-27 2016-08-03 玫琳凯有限公司 植物性抗痤疮制剂
EP2345646A1 (en) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR101330190B1 (ko) 2011-09-20 2013-11-15 (주)그린솔루션스 하고초 추출물의 헴 옥시게나아제-1 발현 조절을 통한 지방 생성 억제용 화장료 조성물
DE202012013018U1 (de) 2011-12-19 2014-08-20 Mary Kay Inc. Kombination von Pflanzenextrakten zur Verbesserung des Hauttons
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
ITMI20121727A1 (it) * 2012-10-12 2014-04-13 Indena Spa Formulazioni per il trattamento e la prevenzione dell'obesita'
ITMI20121749A1 (it) * 2012-10-16 2014-04-17 Indena Spa Estratti di helianthus annuus utili nel trattamento della sindrome metabolica e nella diminuzione dell'indice glicemico di alimenti e procedimento per la loro preparazione e composizioni che li contengono
KR102323049B1 (ko) 2014-03-10 2021-11-05 마리 케이 인코포레이티드 피부 라이트닝 조성물
DE202014005450U1 (de) * 2014-07-04 2015-10-06 Ursapharm Arzneimittel Gmbh Lactosefreies Arzneimittel
US20160302451A1 (en) * 2015-04-16 2016-10-20 Michael Hudnall Medical Food for Patients with Chronic Liver Disease
FR3075570B1 (fr) * 2017-12-22 2020-01-03 Agro Innovation International Stimulation de la nitrification d'un sol avec des compositions comprenant un extrait de plante
IT201900000367A1 (it) * 2019-01-10 2020-07-10 Altergon Sa Composizioni comprendenti un peptide in grado di stimolare la via del segnale gprc6a-dipendente
CN110433280A (zh) * 2019-09-11 2019-11-12 周口师范学院 植物血凝素在制备预防或治疗肥胖药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
WO2007006391A2 (en) * 2005-07-14 2007-01-18 Indena S.P.A. Cynara scolymus extracts, the use thereof ans formulations containing them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
ITMI20052450A1 (it) 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
WO2007006391A2 (en) * 2005-07-14 2007-01-18 Indena S.P.A. Cynara scolymus extracts, the use thereof ans formulations containing them

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Eduardo Pe´rez-Campos等.Erythroagglutinin from Phaseolus coccineus Var. Alubia: Chemical Characterization, Sugar Specificity, and Effect on Blood Coagulation Factors.《Journal of Agricultural and Food Chemistry》.1997,第45卷(第10期),3747-3752. *
Geoffrey G. Irish等.A new assay for functional lectins: the brush border lectin agglutination assay (BBLAA).《Animal Feed Science and Technology》.1999,第76卷321-333. *
YEWANDE O. FASINA等.A Semi-Pilot-Scale Procedure for Isolating and Purifying Soybean (Glycine max) Lectin.《Journal of Agricultural and Food Chemistry》.2003,第45卷(第16期),4532-4538. *

Also Published As

Publication number Publication date
AU2008224057A1 (en) 2008-09-12
AU2008224057B2 (en) 2012-07-19
IL200709A0 (en) 2010-05-17
PT1967198E (pt) 2009-06-15
KR20090118051A (ko) 2009-11-17
IL200709A (en) 2013-07-31
US20100136145A1 (en) 2010-06-03
BRPI0808563B1 (pt) 2018-02-14
NO339322B1 (no) 2016-11-28
CN101641111A (zh) 2010-02-03
RU2009133338A (ru) 2011-03-10
US20080220097A1 (en) 2008-09-11
JP2010520246A (ja) 2010-06-10
RU2453323C2 (ru) 2012-06-20
EP1967198B1 (en) 2009-05-13
BRPI0808563A2 (pt) 2014-09-02
JP5355424B2 (ja) 2013-11-27
ATE431155T1 (de) 2009-05-15
US7887854B2 (en) 2011-02-15
CA2680078A1 (en) 2008-09-12
EP1967198A1 (en) 2008-09-10
KR101456555B1 (ko) 2014-10-31
ES2323815T3 (es) 2009-07-24
DE602007001128D1 (de) 2009-06-25
WO2008107184A1 (en) 2008-09-12
SI1967198T1 (sl) 2009-08-31
US7887855B2 (en) 2011-02-15
NO20100527A1 (no) 2010-05-19
HK1121694A1 (en) 2009-04-30
CA2680078C (en) 2016-12-06
PL1967198T3 (pl) 2009-10-30
DK1967198T3 (da) 2009-08-10

Similar Documents

Publication Publication Date Title
CN101641111B (zh) 包含用于治疗肥胖症的菜蓟与菜豆提取物的制剂
EP1633379A1 (en) Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease
WO2009147228A1 (en) Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism
EP1583547B1 (en) Anti-obesity ingredients from medicinal plants and their composition
US7553502B2 (en) Formulations of alpha-amylase inhibitors with alpha-glucosidase inhibitors useful in the treatment of diabetes and obesity
WO2008107182A2 (en) Formulations of al pha-amylas e inhibitors of p. vulgaris with alpha-glucos idade inhibitores of s. oblonga or s. reticulata useful in the treatment of diabetes and obesity
CN110548039A (zh) 一种针对食源性肥胖的减肥药物及制备方法
MONDAL Fagopyrum esculentum: A Nutrient-Dense Part of Nature
JP2011012021A (ja) 血糖コントロール用組成物
EP2155220B1 (en) Compositions comprising Herba Ephedrae and Thallus Laminariae seu Eckloniae for use in supressing obesity
HK1121694B (en) Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity
JP2009269896A (ja) 抗糖尿病食品または医薬品素材及び抗糖尿病食品または医薬品
CN109966283A (zh) 脱脂肉桂多酚提取物在制备防治糖尿病肾病产品中的应用
TWI832945B (zh) 血糖值上昇抑制用、血中三酸甘油酯上昇抑制用組成物
JP2007070263A (ja) 糖尿病予防用組成物
KR20240155406A (ko) 배초향 추출물을 유효성분으로 함유하는 장내 항 염증 및 장내 환경 개선용 조성물
CN121081542A (zh) 治疗良性前列腺增生的组合物和方法，以及制备用于其的二萜类组合物的方法
CN115708533A (zh) 一种预防和改善心脑血管疾病的功能茶及其制备方法
HK1121696A (en) Formulations of alpha-amylase inhibitors of p. vulgaris with alpha-glucosidade inhibitores of s. oblonga or s. reticulata useful in the treatment of diabetes and obesity
AU2006328982A1 (en) Ethanol-preci pitated Phaseolus vulgaris extracts, their use and formulations

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120523